Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Radovich Insider Profile
4 Followers
Peter Radovich, SVP, Operations at Global Blood Therapeutics, holds 27.02K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 0.00 shares in Rain Oncology (Ticker: RAIN), holds 8.83K shares in Global Blood Therapeutics (Ticker: GBT). Most recently, Peter Radovich Sold ― shares of Mirum Pharmaceuticals on Jan 08, 2025 for an estimated value of 85.53K.
Peter Radovich Global Blood Therapeutics (GBT)SVP, Operations
Global Blood Therapeutics (GBT)
SVP, Operations
Ranked #93,274 out of 100,285 Corporate Insiders
Profitable Transactions
1 out of 8 Profitable Transactions
Average Return
-36.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & COO
Roles that Peter Radovich holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Radovich
Peter Radovich's Trading History
Global Blood Therapeutics
Oct 31, 2017
―
Uninformative Sell
437.50K
$604.97K
Mirum Pharmaceuticals
Jan 08, 2025
President & COO
Informative Sell
85.53K
$1.27M
Rain Oncology
Jan 26, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Peter Radovich's performance on stock
You May Also Like
Peter Radovich insider profile FAQ
What is the percentage of profitable transactions made by Peter Radovich?
The percentage of profitable transactions made by Peter Radovich is 13%.
What is the average return per transaction made by Peter Radovich?
The average return per transaction made by Peter Radovich is -36.30%.
What stocks does Peter Radovich hold?
Peter Radovich holds: GBT, MIRM, RAIN stocks.
What was Peter Radovich’s latest transaction?
Peter Radovich latest transaction was an Informative Sell of $85.53K.
What was Peter Radovich's most profitable transaction?
Peter Radovich’s most profitable transaction was an Informative Sell of MIRM stock on January 8, 2025. The return on the trade was 1.60%.
What is Peter Radovich's role in Global Blood Therapeutics?
Peter Radovich's role in Global Blood Therapeutics is SVP, Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.